Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroup

The survival of patients with myelodysplastic syndromes is strongly affected by chromosomal abnormalities. Patients with an isolated del(5q31) have a favourable prognosis that worsens with the addition of another chromosomal abnormality. It has been reported that both patients with isolated del(5q31...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2005-09, Vol.84 (9), p.569-571
Hauptverfasser:	Giagounidis, A A N, Germing, U, Strupp, C, Hildebrandt, B, Heinsch, M, Aul, C
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Chromosome Aberrations Chromosome Deletion Chromosomes, Human, Pair 5 Humans Karyotyping Middle Aged Myelodysplastic Syndromes - drug therapy Myelodysplastic Syndromes - genetics Myelodysplastic Syndromes - mortality Prognosis Remission Induction Survival Rate Thalidomide - analogs & derivatives Thalidomide - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!